Purchase Order 36C26020P0402
- Not listed
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The one-year, $808,537.12 delivery order contract is for Firm Fixed Price infectious disease testing products and services, including molecular diagnostic testing, COVID-19 testing reagents and equipment, maintenance services, and supply of reagents and test...
- The Department of Veterans Affairs Veterans Health Administration (VHA) awarded a firm fixed price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit organization, to provide COVID-19 testing kits. The $230,850 contract has a period of performance from July 2020 to July 2021 and is not associated with a set-aside program. Biofire Diagnostics is a leader in syndromic infectious disease testing and has received numerous federal contracts to provide diagnostic testing services,...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide COVID-19 testing reagents. The $223,560 firm fixed-price purchase order has a completion date of September 30, 2021. Biofire Diagnostics LLC has received numerous federal contracts to supply infectious disease testing products and services, including molecular diagnostic testing, reagents, and maintenance...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, a $126,652.50 firm-fixed-price purchase order for BioFire RP2.1 panel reagents. The contract has a completion date of February 15, 2022 and was awarded on December 3, 2020. Biofire Diagnostics is a leader in syndromic infectious disease testing and has received numerous federal contracts from agencies such as the VA, Defense Health Agency,...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The contract, which has a potential value of $883,594.79, is a Blanket Purchase Agreement (BPA) call under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The...
- This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The $121,440.00 firm fixed-price contract is for the provision of BIOFIRE diagnostic products and services, issued under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents,...
- The Department of Veterans Affairs Veterans Health Administration (VA VHA) awarded a Delivery Order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide EMERGENCY BIOFIRE FILM ARRAY diagnostic products. The $210,076.64 firm-fixed-price contract supports the Coronavirus COVID-19 National Interest Action and was issued against Biofire's existing GSA Federal Supply Schedule contract for in-vitro diagnostics. Biofire Diagnostics is a leader in syndromic infectious...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a delivery order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide BIOFIRE RFIT-ASY-0124 test kits for coronavirus. The order, valued at $146,247.18, was issued against Biofire's General Services Administration Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract has no set-aside designation and is for Firm Fixed Price delivery of the...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $278,800 firm fixed-price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, for the BIOFIRE FA TORCH SYSTEM. The contract was awarded under the Coronavirus COVID-19 National Interest Action Code and does not have a set-aside designation. Biofire Diagnostics LLC is the leader in syndromic infectious disease testing and has received numerous federal contracts to provide...
- This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotechnology company. The $174,974.00 Blanket Purchase Agreement (BPA) Call contract is for medical cost per test services, with a firm fixed price pricing type. The contract has no set-aside designation. Biofire Diagnostics is a leader in syndromic infectious disease testing and has received multiple awards from the VA...
This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit organization that specializes in syndromic infectious disease testing. The $125,500.00 firm-fixed-price purchase order does not have a set-aside designation. Biofire Diagnostics LLC has received numerous federal contracts as a prime contractor to provide a variety of goods and services related to infectious disease testing, including molecular diagnostic testing services and products, COVID-19 testing reagents and equipment, maintenance services, and supply of reagents and test kits. Major customers include the VA VHA and its Veterans Integrated Service Networks, the Defense Health Agency, Indian Health Service, and the Department of State. Biofire Diagnostics LLC holds several indefinite delivery contracts and blanket purchase agreements to facilitate ongoing procurement of its infectious disease testing products and services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $125.5k | 3/5/20 |